Tradestie Institutional Equity Comparison Engine

TWST vs VCYT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TWST Overall Edge

TWST Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Twist Bioscience Corporation Common Stock (TWST) driven by superior Momentum & Technical, Options & Structure while VCYT counters with relative strength in Valuation, Growth & Margin. Fundamentally, TWST trades at N/M Forward P/E with -28.8% operating margin (+27.9% YoY revenue) versus VCYT at 15.3x Forward P/E and 15.0% operating margin (+15.1% YoY). In options structure, TWST sits in CONSOLIDATION (19th %ile IV; Dealer Gamma Walls on Pro) against VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VCYT
TWST N/M vs VCYT 15.3x Fwd P/E
Growth & Margin Winner VCYT
Op Margin -28.8% vs 15.0% ยท YoY +27.9% vs +15.1%
Momentum & Technical Winner TWST
1Y +251.3% vs -39.8% ยท 52W Pos 42% vs 5%
Options & Structure Winner TWST
CONSOLIDATION (19th %ile IV) vs BREAKDOWN (47th %ile IV)
TWST NASDAQ
Twist Bioscience Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$105.04
-5.88% 1D
Market Cap $7.4B
1M Return -20.87%
1Y Return +251.3%
Forward P/E N/M
Unified AI Score
51.7 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 68.0 Mom 64.0
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.01
-1.32% 1D
Market Cap $2.0B
1M Return -44.32%
1Y Return -39.78%
Forward P/E 15.3x
Unified AI Score
49.1 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TWST +251.3% VCYT -39.78% Spread: +291.08 pp (TWST Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period TWST Revenue VCYT Revenue TWST Op. Margin VCYT Op. Margin Margin Edge
FY2018 $30M $90M -277.5% -24.2% VCYT
FY2019 $50M $120M -200.1% -12.6% VCYT
FY2020 $90M $120M -155.5% -30.1% VCYT
FY2021 $130M $220M -115.4% -37.3% VCYT
FY2022 $200M $300M -115.3% -13.9% VCYT
FY2023 $250M $360M -88.6% -23.8% VCYT
FY2024 $310M $450M -70.6% 3.6% VCYT
FY2025 $380M $520M -36.2% 11.2% VCYT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TWST (5) vs VCYT (5)
Institutional Metric TWST VCYT Criterion Row Winner
Market Capitalization Scale $7.4B $2.0B Larger Scale TWST
Trailing P/E Ratio Valuation N/M 15.8x Lower Multiple VCYT
Forward P/E Ratio Valuation N/M 15.3x Lower Multiple VCYT
Revenue Growth (YoY) Growth +27.9% +15.1% Higher Growth TWST
Operating Margin (TTM) Profitability -28.8% 15.0% Higher Margin VCYT
Net Profit Margin Profitability -28.3% 21.8% Higher Margin VCYT
Return on Equity (ROE) Capital Efficiency -19.1% 9.4% Higher ROE VCYT
52-Week Range Position Momentum 42% ($23โ€“$220) 5% ($22โ€“$61) Stronger Trend TWST
Beta / 30D Volatility Risk Regime 3.13ฮฒ ยท 126% Vol 3.01ฮฒ ยท 199% Vol Lower Realized Risk TWST
Unified Institutional Score Composite Signal 51.7 / 100 (HOLD) 49.1 / 100 (HOLD) Higher Composite TWST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TWST vs VCYT Buy Guide
TWST CONSOLIDATION
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 19th %ile
IV Regime Compressed (<25th %ile)
Live TWST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VCYT BREAKDOWN
99d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TWST nor VCYT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.